Product NDC: | 0074-3045 |
Proprietary Name: | Cardizem LA |
Non Proprietary Name: | Diltiazem Hydrochloride |
Active Ingredient(s): | 120 mg/1 & nbsp; Diltiazem Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0074-3045 |
Labeler Name: | AbbVie Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021392 |
Marketing Category: | NDA |
Start Marketing Date: | 20101225 |
Package NDC: | 0074-3045-30 |
Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-3045-30) |
NDC Code | 0074-3045-30 |
Proprietary Name | Cardizem LA |
Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-3045-30) |
Product NDC | 0074-3045 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Diltiazem Hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20101225 |
Marketing Category Name | NDA |
Labeler Name | AbbVie Inc. |
Substance Name | DILTIAZEM HYDROCHLORIDE |
Strength Number | 120 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |